Stay updated on Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section reorganized: a single 'Locations' section now lists Córdoba, Coruña, Gran Canaria, Madrid, Navarre, Pontevedra, and Vizcaya, replacing the prior separate 'X Locations' headers. The page shows a revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section updated to clarify that publications are voluntarily provided and may be about the results, and that PubMed-derived publications are auto-filled; the revision version is updated to v3.3.2, replacing the previous language from v3.2.0.SummaryDifference0.4%

- Check48 days agoChange DetectedRemoved a notice about lapse in government funding and NIH Clinical Center operations. The page's core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedPage content remains focused on the NADIM trial details with no substantive updates. No new sections or deletions were detected between screenshots.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page.